Literature DB >> 17195197

Hemodynamic improvement is faster after percutaneous ASD closure than after surgery.

Anneli Eerola1, Jaana I Pihkala, Talvikki Boldt, Ilkka P Mattila, Tuija Poutanen, Eero Jokinen.   

Abstract

OBJECTIVES: Hemodynamic effects of surgical and percutaneous closure of atrial septal defect (ASD) were evaluated.
BACKGROUND: ASD causes volume overload of right ventricle (RV) and is associated with distortion and dysfunction of left ventricle (LV). The amount and timing of hemodynamic changes after ASD closure are not well known.
METHODS: The study group consisted of 7 children treated surgically and 17 treated in the catheterization laboratory. In the control group, there were 51 healthy children. RV size and LV end-diastolic and systolic dimensions, volumes, and function were examined by two- and three- dimensional echocardiography and serum concentrations of natriuretic peptides measured prior to ASD closure, and 1, 6, and 12 months thereafter.
RESULTS: In all children with ASD, during the 1-year follow-up, the z score of RV end-diastolic diameter decreased from a median 5.00 SD to 2.25 SD (P < 0.001). Dilatation of RV did not resolve entirely during 1-year follow-up in either treatment group. End-diastolic LV diameter increased from -1.50 to -0.50 SD (P < 0.001). LV size increased slower in the surgical subgroup but reached control levels in both groups. Concentrations of natriuretic peptides increased during the first month after ASD closure and normalized thereafter in patients treated percutaneously but remained higher than in controls in patients treated surgically.
CONCLUSIONS: During 1-year follow-up after ASD closure, RV size decreases but does not normalize in all patients. The size of the LV normalizes after ASD closure but the increase in LV size is slower in patients treated surgically. Serum levels of ANPN and proBNP are elevated prior to ASD closure but decrease thereafter to control levels in patients treated with the percutaneous technique but not in those treated surgically. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17195197     DOI: 10.1002/ccd.20962

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Effects of age on hemodynamic changes after transcatheter closure of atrial septal defect: importance of ventricular diastolic function.

Authors:  Satoshi Masutani; Mio Taketazu; Hirotaka Ishido; Yoichi Iwamoto; Shigeki Yoshiba; Tamotsu Matsunaga; Toshiki Kobayashi; Hideaki Senzaki
Journal:  Heart Vessels       Date:  2011-03-18       Impact factor: 2.037

2.  Percutaneous atrial septal defect closure in infants and toddlers: predictors of success.

Authors:  Christopher J Petit; Henri Justino; Ricardo H Pignatelli; Matthew A Crystal; William A Payne; Frank F Ing
Journal:  Pediatr Cardiol       Date:  2012-07-18       Impact factor: 1.655

3.  Serum Levels of Natriuretic Peptides in Children before and after Treatment for an Atrial Septal Defect, a Patent Ductus Arteriosus, and a Coarctation of the Aorta-A Prospective Study.

Authors:  Anneli Eerola; Eero Jokinen; Talvikki Boldt; Ilkka P Mattila; Jaana I Pihkala
Journal:  Int J Pediatr       Date:  2010-04-20

4.  Assessment of right atrial and right ventricular size in children after percutaneous closure of secundum atrial septal defect with Amplatzer septal occluder.

Authors:  Beata Kucinska; Bożena Werner; Maria Wróblewska-Kałużewska
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

5.  Mid-Term Outcome of Left Ventricle Reverse Remodeling After Atrial Septal Defect Closure: A Comparison Between Surgical and Device Groups.

Authors:  Muflih Albalawi; Salim Ahmad; Mohamed Al Nasef; Abdulmajeed Alotay; Najlaa Al Rajaa; Atif Alsahari; Irfan Saleem; Jassim Mohamed Abudlhamed
Journal:  Pediatr Cardiol       Date:  2022-03-24       Impact factor: 1.838

6.  Midterm Follow-up Results of Transcatheter Interatrial Septal Defect Closure.

Authors:  Mehdi Ghaderian; Mohammad Reza Sabri; Ali Reza Ahmadi; Mohammad-Reza Alipour; Bahare Dehghan; Mahdie Mehrpour
Journal:  Heart Views       Date:  2019 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.